Advanced Enzyme

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE837H01020
  • NSEID: ADVENZYMES
  • BSEID: 540025
INR
357.30
-1.9 (-0.53%)
BSENSE

May 08

BSE+NSE Vol: 4.54 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
203.37
171.95
184.53
185.91
167.18
169.11
146.10
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
203.37
171.95
184.53
185.91
167.18
169.11
146.10
Raw Material Cost
55.96
45.64
48.74
43.97
45.94
36.76
39.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.97
-4.23
-4.18
6.08
0.15
2.07
-6.36
Employee Cost
41.94
41.26
39.37
39.71
36.84
34.52
35.52
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.00
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
41.27
39.93
40.53
39.72
38.64
40.51
35.46
Total Expenditure (Excl Depreciation)
140.14
122.60
124.47
129.48
121.57
113.86
103.68
Operating Profit (PBDIT) excl Other Income
63.23
49.35
60.06
56.43
45.61
55.25
42.42
Other Income
7.23
8.47
10.28
8.85
8.75
7.69
9.62
Operating Profit (PBDIT)
70.46
57.82
70.34
65.28
54.36
62.94
52.04
Interest
0.57
0.57
0.72
0.76
0.81
0.94
0.93
Exceptional Items
0.11
11.25
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
70.00
68.50
69.62
64.52
53.55
62.00
51.11
Depreciation
10.19
10.21
10.08
9.62
10.08
8.97
8.90
Profit Before Tax
59.80
58.29
59.54
54.90
43.46
53.02
42.21
Tax
14.55
15.11
14.81
14.46
16.73
14.15
8.82
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
45.25
43.18
44.73
40.44
26.73
38.88
33.39
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
45.25
43.18
44.73
40.44
26.73
38.88
33.39
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
2.29
0.68
1.41
0.51
0.25
1.23
0.56
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
42.96
42.50
43.33
39.93
26.48
37.65
32.83
Equity Capital
22.39
22.39
22.38
22.38
22.38
22.38
22.37
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
3.84
3.8
3.87
3.57
2.37
3.36
2.94
Diluted Earnings per share
3.84
3.79
3.87
3.57
2.37
3.36
2.93
Operating Profit Margin (Excl OI)
31.09%
28.7%
32.55%
30.35%
27.28%
32.67%
29.03%
Gross Profit Margin
34.42%
39.84%
37.73%
34.7%
32.03%
36.66%
34.98%
PAT Margin
22.25%
25.11%
24.24%
21.75%
15.99%
22.99%
22.85%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Mar 2026 is 21.65% vs 5.93% in Mar 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Mar 2026 is 62.24% vs -6.46% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is 38.63% vs -17.64% in Mar 2025

stock-summary

Interest

YoY Growth in quarter ended Mar 2026 is -29.63% vs -4.71% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025

Compare Quarterly Results Of Advanced Enzyme With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
203.37
0
203.37
Other Operating Income
0.00
0.00
0.00
Total Operating income
203.37
0
203.37
Raw Material Cost
55.96
0
55.96
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.97
0
0.97
Employee Cost
41.94
0
41.94
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
41.27
0.00
41.27
Total Expenditure (Excl Depreciation)
140.14
0
140.14
Operating Profit (PBDIT) excl Other Income
63.23
0.00
63.23
Other Income
7.23
0
7.23
Operating Profit (PBDIT)
70.46
0
70.46
Interest
0.57
0
0.57
Exceptional Items
0.11
0
0.11
Gross Profit (PBDT)
70.00
0
70.00
Depreciation
10.19
0
10.19
Profit Before Tax
59.80
0
59.80
Tax
14.55
0
14.55
Provisions and contingencies
0.00
0
0.00
Profit After Tax
45.25
0
45.25
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
45.25
0
45.25
Share in Profit of Associates
0.00
0
0.00
Minority Interest
2.29
0
2.29
Other related items
0.00
0.00
0.00
Consolidated Net Profit
42.96
0
42.96
Equity Capital
22.39
0
22.39
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
3.84
0
3.84
Diluted Earnings per share
3.84
0
3.84
Operating Profit Margin (Excl OI)
31.09%
0%
0.00
31.09%
Gross Profit Margin
34.42%
0%
0.00
34.42%
PAT Margin
22.25%
0%
0.00
22.25%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 203.37 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 18.27% vs -6.82% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 21.65% vs 5.93% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 42.96 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 1.08% vs -1.92% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 62.24% vs -6.46% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 63.23 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 28.13% vs -17.83% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 38.63% vs -17.64% in Mar 2025

Quarterly - Interest
Interest 0.57 Cr
in Mar 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.00% vs -20.83% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -29.63% vs -4.71% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.09%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has improved from Mar 2025